These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 3884150)
1. Dopamine agonists in the treatment of dystonia. Lang AE Clin Neuropharmacol; 1985; 8(1):38-57. PubMed ID: 3884150 [No Abstract] [Full Text] [Related]
2. Lisuride in dystonia. Quinn NP; Lang AE; Sheehy MP; Marsden CD Neurology; 1985 May; 35(5):766-9. PubMed ID: 3887215 [TBL] [Abstract][Full Text] [Related]
3. General discussion of drug therapy in dystonia. Adv Neurol; 1976; 14():417-22. PubMed ID: 941782 [No Abstract] [Full Text] [Related]
4. [Experience with L-DOPA treatment of children with dystonia musculorum deformans and dystonic hyperkineses in infantile cerebral palsy]. Bondarenko ES; Malyshev IuI Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(10):1471-5. PubMed ID: 4072505 [TBL] [Abstract][Full Text] [Related]
5. Open label evaluation of cannabidiol in dystonic movement disorders. Consroe P; Sandyk R; Snider SR Int J Neurosci; 1986 Nov; 30(4):277-82. PubMed ID: 3793381 [TBL] [Abstract][Full Text] [Related]
6. Medical treatment of dystonia. Pakkenberg H; Pedersen B Psychopharmacology Suppl; 1985; 2():111-7. PubMed ID: 2860654 [TBL] [Abstract][Full Text] [Related]
7. [Diagnostic and therapeutic problems in dystonia musculorum deformans]. Fraioli B; Contratti F; Baldassarre L Riv Neurol; 1976; 46(1):73-80. PubMed ID: 796956 [TBL] [Abstract][Full Text] [Related]
12. Positron tomography in dystonia. Lang AE; Garnett ES; Firnau G; Nahmias C; Talalla A Adv Neurol; 1988; 50():249-53. PubMed ID: 3261117 [No Abstract] [Full Text] [Related]
13. Dystonia musculorum deformans: implications of therapeutic response to levodopa and carbamazepine. Garg BP Arch Neurol; 1982 Jun; 39(6):376-7. PubMed ID: 7092616 [TBL] [Abstract][Full Text] [Related]
14. [Description of a case of dystonia musculorum deformans treated with L-dopa]. Balottin U; Lanzi G; Zambrino CA Riv Neurobiol; 1981; 27(34):584-90. PubMed ID: 7052665 [No Abstract] [Full Text] [Related]
16. Hereditary progressive dystonia with marked diurnal fluctuation--consideration on its pathophysiology based on the characteristics of clinical and polysomnographical findings. Segawa M; Nomura Y; Tanaka S; Hakamada S; Nagata E; Soda M; Kase M Adv Neurol; 1988; 50():367-76. PubMed ID: 3041759 [No Abstract] [Full Text] [Related]
17. Long-term treatment with levodopa in a family with autosomal dominant torsion dystonia. de Yebenes JG; Moskowitz C; Fahn S; Saint-Hilaire MH Adv Neurol; 1988; 50():101-11. PubMed ID: 3400489 [No Abstract] [Full Text] [Related]
18. Therapeutics of disordered movement. Sears ES Am Fam Physician; 1977 Sep; 16(3):145-54. PubMed ID: 143204 [TBL] [Abstract][Full Text] [Related]
19. Long-term levodopa therapy for torsion dystonia. Still CN; Herberg KP South Med J; 1976 May; 69(5):564-6. PubMed ID: 1273612 [TBL] [Abstract][Full Text] [Related]